Company Overview and News

32
Union leaders to meet General Electric in bid to save Virginia jobs

2018-06-12 reuters
NEW YORK (Reuters) - Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE’s power plants, the company and the union said on Tuesday.
ABB GEC GE ABLZF GNE

32
Union leaders to meet General Electric in bid to save Virginia jobs

2018-06-12 channelnewsasia
Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE's power plants, the company and the union said on Tuesday.
ABB GEC GE ABLZF GNE

32
Union leaders to meet General Electric in bid to save Virginia jobs

2018-06-12 reuters
NEW YORK, June 12 (Reuters) - Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE’s power plants, the company and the union said on Tuesday.
ABB GEC GE ABLZF GNE

23
China's Solar Demand Shock Is Not So Simple

2018-06-12 seekingalpha
But what is China doing here? What has caused this move, and what might cause different policy developments in the years to come?
ABB RUN ABLZF FSLR

108
3 Robotic Stocks That Can Electrify Your Portfolio

2018-05-31 investorplace
It doesn’t take a rocket scientist to understand that society is rapidly shifting towards digitalization. With cloud-computing being one of the most popular buzz words, we can easily see that an increasing number of functions are pushed into the intangible sphere. However, the physical realm isn’t going away; it’s just getting smarter. Hence, you’ll want to consider robotic stocks for your portfolio.
ABB AMZN ABLZF ISRG

753
20 2018 Losers That Will Be Big Winners

2018-05-27 investorplace
Choppy trading this year has created buying opportunities in the market. After a 14-month bull run sent stocks of all kinds soaring, there have been a few stocks this year that have seen unwarranted sell-offs. Those “rebound stocks,” for lack of a better term, have been caught in market concerns about rising Treasury yields and a potential trade war, among other factors.
STZ.B NTRI AMT.PRB AMT.PRA WBA GS.PRB GS.PRA CVS GTN.A CAA GLSSP AMZN AMT VIAB GM.WS.A GM.WS.B AVGO GM.WS.C ABLZF UBS.PRDCL ED BGS MIK JBK GE TMUSP TMUS TFG STZ CBS.WD GS.PRJ GS.PRI GTN GS.PRD NX GS.PRC VZ LVS CPV QCOM FCAU GM.WSB GS.PRN GS.PRK MGM LEN RAD LEN.B VZA GS UBS AAPL GM INTC LUV CBS VIA F GEC WYNN GSC GS.PRICL CBS.A CRUS GSJ ABB S T KHC GNE BRCM GJS ULSGF

166
Top Analyst Reports for Procter & Gamble, AbbVie, McDonald's & PepsiCo

2018-05-21 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 17 major stocks, including Procter & Gamble (PG), AbbVie (ABBV), McDonald’s (MCD) and PepsiCo (PEP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
HD MKGAF GD UPS ABB SRE.PRA PEP MKGAY SRE AMAT ABLZF ABBV CSX ABBV MCD

19
A $28 Billion Deal Defeat Turns Sweet for Emerson - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ABB ABLZF ROK

39
DoE lists substations suitable to take in new power plant capacity

2018-04-29 bworldonline
THE Department of Energy (DoE) has listed 14 areas with newly built substations to guide would-be power plant developers hoping to connect to the transmission system.
ABB MER GEC GE NG NGGTF ABLZF GNE NGG

23
In remote China, a high-tech auto plant flags global challenge

2018-04-27 reuters
ZHANGJIAKOU, China (Reuters) - While auto workers in Germany and South Korea fight to save their jobs, one of China’s youngest auto brands is gearing up to build sport utility vehicles at a new factory with digitally-connected robots and a fresh workforce of 1,800 people.
GELYF UG GELYY DDAIF 0175 ABB GM.WS.A GM.WS.B GM.WS.C ABLZF GM GM.WSB ROK

55
Europe Wants a Robot Army to Challenge the U.S. and China on AI - Bloomberg

2018-04-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ABB FB 0700 ABLZF

18
Nasdaq Announces Results from 2018 Annual Meeting of Stockholders

2018-04-24 globenewswire
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq:NDAQ) stockholders today elected all nominated directors at the company’s Annual Meeting of Stockholders. All directors will serve one-year terms. Elected board members include:
ABB ABLZF

18
Europe’s Depopulation Time Bomb Is Ticking in the Baltics - Bloomberg

2018-04-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ABB ABLZF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: H0010V101